Trinity Biotech plc
TRIB
$0.34
$0.00-1.43%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -17.48M | -5.97M | -16.96M | -4.76M | -8.95M |
| Total Depreciation and Amortization | -652.00K | 657.00K | -766.00K | 598.00K | 744.00K |
| Total Amortization of Deferred Charges | 1.38M | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.55M | 2.56M | 13.46M | 2.42M | 8.72M |
| Change in Net Operating Assets | 1.73M | 1.05M | 6.42M | -1.88M | 153.00K |
| Cash from Operations | -1.48M | -1.71M | 3.35M | -3.62M | 676.00K |
| Capital Expenditure | 11.00K | -37.00K | -157.00K | -110.00K | -321.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -815.00K | -1.93M | -2.58M | -2.99M | -1.00M |
| Cash from Investing | -804.00K | -1.97M | -2.74M | -3.10M | -1.32M |
| Total Debt Issued | 7.00M | 2.00M | 2.00M | -- | -- |
| Total Debt Repaid | -858.00K | -793.00K | -665.00K | -678.00K | -684.00K |
| Issuance of Common Stock | 0.00 | -- | 544.00K | 7.12M | -- |
| Repurchase of Common Stock | -- | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -77.00K | -79.00K | -74.00K | -2.20M | -1.69M |
| Cash from Financing | 6.07M | 1.13M | 1.81M | 4.24M | -2.37M |
| Foreign Exchange rate Adjustments | 11.00K | 26.00K | -93.00K | 5.00K | -179.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.80M | -2.52M | 2.33M | -2.48M | -3.20M |